View Cart (0 items)

Articles Tagged with ''pharmaceutical industry''

New FDA requirements to increase costs for Indian drug makers

No Comments
The U.S. Food and Drug Administration (FDA) is introducing more stringent regulation regarding quality standards for drug products manufacturing, which will push up costs for Indian drug producers.
Read More

'High Containment' Powder Handling Solutions

No Comments
Spiroflow Systems specializes in "high containment" powder handling solutions and offer a range of bulk bag unloaders specifically for use in pharmaceutical applications.
Read More

Omnicare to pay $124 million to settle fraud allegations

No Comments
Cincinnati-based Omnicare Inc. is to pay more than $124 million in a settlement with the U.S. Department of Justice for allegedly offering financial incentives to healthcare facilities.
Read More

India's drug makers embrace automation

No Comments
India's second largest drug maker by sales, Dr. Reddy's Laboratories, is embracing automation and making it a critical part of the manufacturing process.
Read More

US regulator to tighten scrutiny on potential drug delay deals

No Comments
The U.S. Federal Trade Commission has announced plans to increase probes into pharmaceutical deals that potentially harm competition by delaying the launch of generic drugs on the market.
Read More

British scientists discover way to fight antibiotic-resistant bacteria

No Comments
Thanks to a new study by researchers at the University of East Anglia (UEA), the fight against antibiotic-resistant bacteria may become easier.
Read More

Merck to take over hepatitis C drug maker

No Comments
American pharmaceutical giant Merck & Co. is planning to buy Idenix Pharmaceuticals Inc., a Massachusetts-based company specializing in developing treatment for hepatitis C.
Read More

Hikma Pharmaceuticals to take over US generic injectables manufacturer

No Comments
London-based multinational company Hikma Pharmaceuticals PLC has reached an asset acquisition agreement with Ben Venue Laboratories for the purchase of its U.S. generic injectables division, Bedford Laboratories, for $300 million.
Read More

US pharma major Abbott to pay $2.9 billion for Chile's CFR

No Comments
U.S. pharmaceuticals and healthcare products major Abbott Laboratories has agreed to acquire Chile-based pharmaceutical firm CFR Pharmaceuticals SA in a deal worth $2.9 billion.
Read More

Sun Pharma's response to FDA import ban seen as 'inadequate'

No Comments
According to the U.S. Food and Drug Administration, Sun Pharma has failed to take sufficient measures to correct the violations that led to the enforcement action.
Read More